Cancer Incidence and Mortality for Wyoming County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 270.0 530.6 501.9-560.6 138.8 553.2 511.0-598.1 131.2 531.8 490.3-576.1 87.2 177.0 160.5-194.9 45.2 200.3 174.1-229.5 42.0 162.1 140.4-186.4
Oral cavity and pharynx 8.2 15.5 11.0-21.3 5.8 22.2 14.5-32.6 2.4 8.5 4.4-15.7 2.0 3.7 1.7-7.1 1.8 6.8 3.0-13.6 0.2 0.8 0.0-5.4
Esophagus 4.4 8.1 5.0-12.6 3.8 13.9 8.2-22.5 0.6 2.4 0.5-7.8 3.0 5.6 3.1-9.5 2.6 10.5 5.4-18.6 0.4 1.4 0.2-6.2
Stomach 3.2 6.3 3.6-10.6 2.2 8.6 4.2-15.9 1.0 4.1 1.2-10.4 0.8 1.6 0.4-4.3 0.6 2.4 0.5-7.6 0.2 0.6 0.0-5.0
Colorectal 21.0 43.6 35.5-53.1 10.6 44.5 32.8-59.0 10.4 42.1 31.1-55.9 7.2 15.3 10.7-21.5 3.8 18.3 10.8-28.9 3.4 12.9 7.3-21.4
Colon excluding rectum 16.4 34.3 27.2-42.8 7.6 33.5 23.4-46.7 8.8 34.3 24.7-46.8 6.0 12.5 8.4-18.1 3.0 13.8 7.5-23.2 3.0 11.4 6.2-19.7
Rectum & rectosigmoid 4.6 9.4 5.8-14.3 3.0 10.9 5.9-18.7 1.6 7.7 3.3-15.6 1.2 2.8 1.0-6.2 0.8 4.5 1.2-11.3 0.4 1.5 0.2-6.3
Liver / intrahepatic bile duct 4.2 7.9 4.8-12.5 3.4 13.7 7.7-22.6 0.8 2.4 0.7-7.4 2.8 5.0 2.7-8.7 1.8 6.1 2.7-12.2 1.0 3.3 1.1-8.7
Pancreas 6.2 12.7 8.6-18.3 3.2 14.0 7.9-23.1 3.0 11.3 6.3-19.4 5.2 10.8 7.0-16.1 3.0 13.1 7.2-22.1 2.2 8.7 4.3-16.2
Larynx 2.4 4.2 2.1-7.7 1.6 5.5 2.3-11.7 0.8 3.4 0.9-9.3 1.4 3.0 1.2-6.4 1.0 5.0 1.6-11.8 0.4 1.6 0.2-6.6
Lung and bronchus 35.0 67.4 57.6-78.5 16.4 67.3 53.0-84.4 18.6 69.5 55.9-85.8 25.4 51.9 43.1-62.0 12.0 53.2 40.2-69.1 13.4 51.4 39.6-65.9
Melanoma of the skin 12.0 24.1 18.3-31.3 8.0 30.7 21.6-42.6 4.0 20.3 12.1-31.8 1.6 3.3 1.4-6.7 1.4 6.0 2.3-12.8 0.2 0.8 0.0-5.4
Female breast             39.6 164.6 141.5-190.6             4.4 16.8 10.5-26.1
Cervix uteri             1.0 5.1 1.5-12.4             0.2 1.0 0.0-6.0
Corpus uterus and NOS             9.6 35.9 26.3-48.2             2.6 9.2 4.9-16.5
Ovary             2.8 10.6 5.6-18.6             1.6 6.4 2.7-13.3
Prostate       35.2 130.2 110.8-152.1             4.2 21.3 13.0-32.9      
Testis       0.6 2.6 0.5-8.0             0.0 0.0 0.0-3.7      
Urinary bladder (incl. in situ) 11.2 23.0 17.2-30.2 8.8 38.3 27.4-52.2 2.4 10.4 5.2-18.9 2.0 4.1 1.9-7.8 1.4 6.9 2.7-14.5 0.6 2.9 0.6-9.1
Kidney and renal pelvis 11.8 21.7 16.4-28.4 8.0 31.0 21.8-43.0 3.8 13.4 8.0-21.8 1.8 3.4 1.5-6.8 1.6 6.4 2.6-13.2 0.2 0.9 0.0-5.8
Brain and other central nervous system 3.4 7.3 4.1-12.0 2.0 9.7 4.5-18.2 1.4 4.7 1.9-10.6 2.8 5.7 3.1-9.9 1.6 6.1 2.5-12.6 1.2 5.0 1.6-11.8
Thyroid 7.2 15.3 10.6-21.6 1.2 4.8 1.6-11.0 6.0 29.5 19.3-43.1 0.0 0.0 0.0-1.9 0.0 0.0 0.0-3.7 0.0 0.0 0.0-4.2
Hodgkin lymphoma 1.6 3.8 1.6-7.6 1.0 4.4 1.4-10.5 0.6 2.8 0.5-8.8 0.0 0.0 0.0-1.9 0.0 0.0 0.0-3.7 0.0 0.0 0.0-4.2
Non-Hodgkin lymphomas 13.4 27.3 21.0-35.0 7.0 29.3 20.1-41.4 6.4 27.3 18.3-39.4 2.4 4.9 2.5-8.8 1.2 5.3 1.8-12.0 1.2 4.5 1.6-10.5
Myeloma 4.2 8.8 5.4-13.6 2.6 11.1 5.8-19.3 1.6 7.0 2.9-14.5 2.8 6.1 3.3-10.4 1.2 5.2 1.8-11.8 1.6 6.8 2.9-13.9
Leukemias 9.6 18.8 13.7-25.2 5.0 20.4 12.9-30.8 4.6 17.9 11.2-27.6 3.6 7.7 4.5-12.4 1.4 6.5 2.6-13.6 2.2 8.9 4.3-16.5

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.